[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: Criteria for release of cats that received I-131 therapy
In a message dated 4/11/2004 12:17:58 AM Pacific Standard Time,
email@philrutherford.com writes:
However, as a practical matter, human patients are apparently not restricted
from release following these everyday procedures.
In fact, 10 CFR 35 allows patients to be released if the expected maximum
dose to another person will not exceed 500 millirem. NUREG 1556, Vol. 9,
Appendix U provides guidance on determining whether or not this limit will be
exceeded. It actually provides that a patient may be released without instruction if
the remaining activity is less than 760 mCi for Tc-99m. Given that the
average dosages for Tc-99m generally don't exceed 25 mCi, and that for other common
nuclides, the numbers are all well over the average dosages administered,
virtually all diagnostic patients are releasable without a second thought.
Part 35 is devoted to human medical use, and the 500 millirem limit
supercedes the 100 millirem limit in Part 20. Veterinary practice does not fall under
Part 35 regulations, therefore must comply with the Part 20 limits. I'm not
saying it makes sense, necessarily, but it does in a way if you follow the
development of the regulations.
Barbara